Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  NeuroImage

• Publication date

  2009-04-01

• Fields of study

  Medicine, Computer Science, Psychology

• Identifiers
  DOI 10.1016/j.neuroimage.2008.07.042PMID 18718541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Normalization in PET group comparison studies - The importance of a valid reference region

  2008influential reference
• Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility

  2007cited by this paper
• CO-PLANAR STEREOTAXIC ATLAS OF THE HUMAN BRAIN 3-DIMENSIONAL PROPORTIONAL SYSTEM: AN APPROACH TO CEREBRAL IMAGING 1988 GUIDE TO THE TNM/pTNM-CLASSIFICATION OF MALIGNANT TUMOURS THIRD EDITION

  2007cited by this paper
• Quantification of Parkinson’s disease-related network expression with ECD SPECT

  2007cited by this paper
• Changes in network activity with the progression of Parkinson's disease.

  2007cited by this paper
• Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy

  2006cited by this paper
• Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment

  2006cited by this paper
• Symmetric Atlasing and Model Based Segmentation: An Application to the Hippocampus in Older Adults

  2006cited by this paper
• Active Surface Approach for Extraction of the Human Cerebral Cortex from MRI

  2006cited by this paper
• Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging

  2006cited by this paper
• Network modulation in the treatment of Parkinson's disease.

  2006cited by this paper
• FDG PET in the differential diagnosis of parkinsonian disorders

  2005influential reference
• The metabolic pathology of dopa‐responsive dystonia

  2005influential reference
• in Diagnostic

  2005cited by this paper
• Three‐dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia

  2005cited by this paper
• Cerebral Blood Flow in Parkinson’s Disease, Dementia with Lewy Bodies, and Alzheimer’s Disease according to Three-Dimensional Stereotactic Surface Projection Imaging

  2005cited by this paper
• Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.

  2005cited by this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004cited by this paper
• Spatially dissociated flow-metabolism coupling in brain activation

  2004cited by this paper
• Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.

  2004cited by this paper
• Regional cerebral blood flow in Parkinson's disease with and without dementia

  2003cited by this paper
• The neural basis of functional brain imaging signals.

  2002cited by this paper
• Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis

  2002cited by this paper
• Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study

  2002cited by this paper
• Metabolic correlates of levodopa response in Parkinson’s disease

  2001cited by this paper
• Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET

  2001cited by this paper
• Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease.

  2001cited by this paper
• Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.

  2001cited by this paper
• A General Statistical Analysis for fMRI Data

  2000cited by this paper
• Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

  2000cited by this paper
• Reproducibility of regional metabolic covariance patterns: comparison of four populations.

  1999cited by this paper
• SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.

  1999influential reference
• The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.

  1999cited by this paper
• Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

  1999influential reference
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cited by this paper
• Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

  1997cited by this paper
• Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.

  1996cited by this paper
• A unified statistical approach for determining significant signals in images of cerebral activation

  1996influential reference
• Cerebral [15O]Water Clearance in Humans Determined by PET: I. Theory and Normal Values

  1996cited by this paper
• Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.

  1996cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Twelve-month follow-up study of regional cerebral blood flow in Parkinson's disease.

  1995cited by this paper
• Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls

  1995cited by this paper
• Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease

  1995cited by this paper
• Cortical glucose metabolism in Parkinson's disease without dementia.

  1994cited by this paper
• [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy].

  1994cited by this paper
• The Metabolic Topography of Parkinsonism

  1994influential reference
• HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.

  1994cited by this paper
• Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space

  1994cited by this paper
• Regional cerebral blood flow imaging with 99mTc-bicisate SPECT in asymmetric Parkinson's disease: studies with and without chronic drug therapy.

  1994cited by this paper
• Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization

  1993cited by this paper
• Positron emission tomography in degenerative disorders of the dopaminergic system

  1992cited by this paper
• Cognitive function and regional cerebral blood flow in Parkinson's disease.

  1992cited by this paper
• SPECT findings in Parkinson's disease associated with dementia.

  1992cited by this paper
• Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia

  1992cited by this paper
• Cerebral glucose metabolism in Parkinson's disease with and without dementia.

  1992cited by this paper
• Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.

  1991cited by this paper
• (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.

  1991cited by this paper
• Cerebral Blood Flow and Dementia in Parkinson's Disease

  1991cited by this paper
• Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP

  1990influential reference
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• The Relationship between Global and Local Changes in PET Scans

  1990influential reference
• Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1989cited by this paper
• [Cerebral blood flow and oxygen metabolism in patients with Parkinson's disease].

  1988cited by this paper
• Cerebral metabolism of parkinsonian primates 21 days after MPTP.

  1988cited by this paper
• [99mTc]-HM-PAO SPECT in Parkinson's Disease

  1988cited by this paper
• Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.

  1987influential reference
• Scaled Subprofile Model: A Statistical Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data

  1987cited by this paper
• Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.

  1986cited by this paper
• Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.

  1985cited by this paper
• Cerebral blood flow and cognitive impairment in Parkinson's disease

  1985cited by this paper
• Regional blood flow in herniparkinsonism

  1985cited by this paper
• Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease

  1985cited by this paper
• The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.

  1985cited by this paper
• Regional blood flow in hemiparkinsonism.

  1985cited by this paper
• Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa

  1985cited by this paper
• Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

  1984cited by this paper
• Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

  1984cited by this paper
• Cerebral Glucose Metabolism in Parkinson’s Disease

  1984cited by this paper
• The effect of normal aging on patterns of local cerebral glucose utilization

  1984cited by this paper
• Regional cerebral blood flow in patients with Parkinson's disease.

  1979cited by this paper
• Regional impairment of cerebral oxidative metabolism in Parkinson's disease.

  1979cited by this paper
• Regional cerebral blood flow.

  1974cited by this paper
• Cerebral blood-flow.

  1972cited by this paper
• NeuroImage

  year unknowncited by this paper

• Hyperglycemia selectively increases cerebral non-oxidative glucose consumption without affecting blood flow

  2025cites this paper
• Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease

  2024cites this paper
• Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

  2024cites this paper
• Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait

  2024cites this paper
• 99mTc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder

  2024cites this paper
• Hyperglycemia selectively increases cerebral non-oxidative glucose consumption without affecting blood flow

  2024cites this paper
• Synaptic Density and Glucose Consumption in Patients with <scp>Lewy Body Diseases</scp> : An [ <scp> ¹¹ C </scp> ] <scp>UCB‐J</scp> and [ <scp> <sup>18

  2023cites this paper
• Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling

  2023cites this paper
• Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study

  2023cites this paper
• Systematic Review and Meta-Analyses of Word Production Abilities in Dysfunction of the Basal Ganglia: Stroke, Small Vessel Disease, Parkinson’s Disease, and Huntington’s Disease

  2022cites this paper
• Metabolic imaging and plasticity.

  2022cites this paper
• Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning

  2022cites this paper
• Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB‐J PET Imaging Study

  2021cites this paper
• Distinct Patterns of Brain Metabolism in Patients at Risk of Sudden Unexpected Death in Epilepsy

  2021cites this paper
• Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats

  2021cites this paper
• Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study

  2021cites this paper
• Comparison of early F-18 Florbetaben PET/CT to Tc-99m ECD SPECT using voxel, regional, and network analysis

  2021cites this paper
• Altered cerebral perfusion and microstructure in advanced Parkinson’s disease and their associations with clinical features

  2021cites this paper
• Dorsal striatal dopamine induces fronto-cortical hypoactivity and implies reduced anxiety and compulsive behaviors in rats

  2021cites this paper
• A survey on functional and cognitive assessment for diagnosing neurodegenerative disorders

  2021cites this paper
• Hypermetabolic Cerebellar Connectome in Alzheimer's Disease

  2020cites this paper
• From Positron to Pattern: A Conceptual and Practical Overview of 18F-FDG PET Imaging and Spatial Covariance Analysis

  2020cites this paper
• Possible neuroprotective effects of rasagiline in Alzheimer’s disease: a SPECT study

  2020cites this paper
• 18F-FDG-PET Hyperactivity in Alzheimer’s Disease Cerebellum and Primary Olfactory Cortex

  2020cites this paper
• Increased cerebral FDG‐PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia

  2020cites this paper
• Comparison of Count Normalization Methods for Statistical Parametric Mapping Analysis Using a Digital Brain Phantom Obtained from Fluorodeoxyglucose-positron Emission Tomography

  2019cites this paper
• Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis

  2019cites this paper
• Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

  2019cites this paper
• Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease: Clinical and Regional Cerebral Blood Flow SPECT Outcomes

  2019cites this paper
• Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies

  2019cites this paper
• FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis

  2018cites this paper
• Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.

  2018cites this paper
• Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET

  2017influential citation
• Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots

  2017cites this paper
• Structural and Functional Brain Changes at Early and Late Stages of Complex Regional Pain Syndrome.

  2017cites this paper
• Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction

  2017cites this paper
• Basal Ganglia Perfusion in Fibromyalgia is Related to Pain Disability and Disease Impact: An Arterial Spin Labeling Study

  2016cites this paper
• Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson’s disease

  2016cites this paper
• Alterations of ASL Blood Perfusion in the Thalamus and VentralIntermediate Thalamic Nucleus in ParkinsonâÂÂs Disease Patients

  2016cites this paper
• Cerebral F18 -FDG PET CT in Children: Patterns during Normal Childhood and Clinical Application of Statistical Parametric Mapping

  2015cites this paper
• Hippocampal Deep Brain Stimulation Reduces Glucose Utilization in the Healthy Rat Brain

  2015cites this paper
• The Neurobiological Basis of the Distress Thermometer: A PET Study in Cancer Patients.

  2015cites this paper
• Troubles exécutifs et dysfonctionnement du contrôle inhibiteur dans la maladie de Parkinson

  2015cites this paper
• Cortical hypermetabolism in MCI subjects: a compensatory mechanism?

  2015cites this paper
• Neurobiology of Disease Quantification of Indirect Pathway Inhibition by the Adenosine A 2 a Antagonist SYN 115 in Parkinson Disease

  2015cites this paper
• Metabolic Connectivity as Index of Verbal Working Memory

  2015cites this paper
• Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer’s Disease Conversion

  2015cites this paper
• Investigating neurophysiological changes in ageing and their relation to recognition memory using advanced MRI

  2014cites this paper
• Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET

  2014cites this paper
• Glucose metabolic patterns in neurodegenerative brain diseases

  2013cites this paper
• Brain Regions Associated With Cognitive Impairment in Patients With Parkinson Disease: Quantitative Analysis of Cerebral Blood Flow Using 123I Iodoamphetamine SPECT

  2013influential citation
• Voxel-based classification of FDG PET in dementia using inter-scanner normalization

  2013cites this paper
• Perfusion deficits in patients with mild traumatic brain injury characterized by dynamic susceptibility contrast MRI

  2013cites this paper
• Validation of parkinsonian disease‐related metabolic brain patterns

  2013cites this paper
• Differentiating between Normal Aging, Mild Cognitive Impairment, and AlzheimerâÂÂs disease with FDG-PET: Effects of Normalization Region and Partial Volume Correction Method

  2013cites this paper
• Sex‐ and Age‐Related Differences in Brain FDG Metabolism of Healthy Adults: An SPM Analysis

  2012cites this paper
• Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.

  2012cites this paper
• Cerebral oxygen metabolism in patients with early Parkinson's disease.

  2012cites this paper
• Glucose metabolism in small subcortical structures in Parkinson’s disease

  2012cites this paper
• The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.

  2012cites this paper
• Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI

  2012cites this paper
• Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.

  2012cites this paper
• Neuroimaging: Current role in detecting pre‐motor Parkinson's disease

  2012cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach

  2012cites this paper
• Abnormal network topographies and changes in global activity: Absence of a causal relationship

  2012cites this paper
• Brain Energy Metabolism and Blood Flow Differences in Healthy Aging

  2012cites this paper
• Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

  2012cites this paper
• Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.

  2012cites this paper
• Contribution of FDG-PET and MRI to improve Understanding , Detection and Differentiation of Dementia

  2011cites this paper
• Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism

  2011cites this paper
• Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues

  2011influential citation
• Magnetic resonance imaging of cognition in Parkinson’s disease

  2011cites this paper
• Contribution of FDG-PET and MRI to improve Understanding, Detection and Differentiation of Dementia

  2011cites this paper
• Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).

  2011cites this paper
• Alzheimer's Disease & Parkinsonism

  2011cites this paper
• Chemotherapy effects on brain glucose metabolism at rest

  2011cites this paper
• Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.

  2011cites this paper
• Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

  2011influential citation
• Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

  2010cites this paper
• Resting Cerebral Blood Flow Alterations in Chronic Traumatic Brain Injury: An Arterial Spin Labeling Perfusion fMRI Study

  2010cites this paper
• Current Opinion in Neurology. Current world literature.

  2010cites this paper
• FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease.

  2010cites this paper
• Functional Representation of Olfactory Impairment in Early Alzheimer's Disease

  2010cites this paper
• Typical cerebral metabolic patterns in neurodegenerative brain diseases

  2010cites this paper
• Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease

  2010cites this paper
• Imaging of compensatory mechanisms in Parkinson's disease.

  2010cites this paper
• B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: Impact on voxel-based statistical single-subject analysis

  2010cites this paper
• Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies

  2010cites this paper
• Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization

  2009cites this paper
• Abnormal regional brain function in Parkinson's disease: truth or fiction?

  2009influential citation
• PET Functional Imaging of Deep Brain Stimulation in Movement Disorders and Psychiatry

  2009cites this paper
• Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

  2009cites this paper
• Subcortical elevation of metabolism in Parkinson's disease - A critical reappraisal in the context of global mean normalization

  2009influential citation
• "Absolute" or "relative": Choosing the right outcome measure in neuroimaging

  2009cites this paper
• The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients

  year unknowncites this paper